Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.
World J Surg Oncol. 2023 Aug 30;21(1):272. doi: 10.1186/s12957-023-03138-y.
Robotic colorectal surgery is becoming the preferred surgical approach for colorectal cancer (CRC). It offers several technical advantages over conventional laparoscopy that could improve patient outcomes. In this retrospective cohort study, we compared robotic and laparoscopic surgery for CRC using a national cohort of patients.
Using the colectomy-targeted ACS-NSQIP database (2015-2020), colorectal procedures for malignant etiologies were identified by CPT codes for right colectomy (RC), left colectomy (LC), and low anterior resection (LAR). Optimal pair matching was performed. "Textbook outcome" was defined as the absence of 30-day complications, readmission, or mortality and a length of stay < 5 days.
We included 53,209 out of 139,759 patients screened for eligibility. Laparoscopic-to-robotic matching of 2:1 was performed for RC and LC, and 1:1 for LAR. The largest standardized mean difference was 0.048 after matching. Robotic surgery was associated with an increased rate of textbook outcomes compared to laparoscopy in RC and LC, but not in LAR (71% vs. 64% in RC, 75% vs. 68% in LC; p < 0.001). Robotic LAR was associated with increased major morbidity (7.1% vs. 5.8%; p = 0.012). For all three procedures, the mean conversion rate of robotic surgery was lower than laparoscopy (4.3% vs. 9.2%; p < 0.001), while the mean operative time was higher for robotic (225 min vs. 177 min; p < 0.001).
Robotic surgery for CRC offers an advantage over conventional laparoscopy by improving textbook outcomes in RC and LC. This advantage was not found in robotic LAR, which also showed an increased risk of serious complications. The associations highlighted in our study should be considered in the discussion of the surgical management of patients with colorectal cancer.
机器人结直肠手术正成为治疗结直肠癌(CRC)的首选手术方法。它相对于传统腹腔镜提供了多项技术优势,这些优势可能改善患者的预后。在这项回顾性队列研究中,我们使用全国性的患者队列比较了机器人与腹腔镜结直肠手术。
使用结直肠切除术为目标的 ACS-NSQIP 数据库(2015-2020 年),通过右结肠切除术(RC)、左结肠切除术(LC)和低位前切除术(LAR)的 CPT 代码确定恶性病因的结直肠手术。进行了最优配对匹配。“教科书结局”定义为 30 天内无并发症、再入院或死亡以及住院时间<5 天。
我们纳入了 53209 例符合条件的筛选患者中的 139759 例。RC 和 LC 进行了腹腔镜到机器人的 2:1 匹配,LAR 进行了 1:1 匹配。匹配后最大标准化均差为 0.048。与腹腔镜相比,机器人手术在 RC 和 LC 中与更高的教科书结局率相关,但在 LAR 中则不然(RC 中为 71%比 64%,LC 中为 75%比 68%;p<0.001)。机器人 LAR 与较高的主要发病率相关(7.1%比 5.8%;p=0.012)。对于所有三种手术,机器人手术的平均转换率均低于腹腔镜(4.3%比 9.2%;p<0.001),而机器人手术的平均手术时间则更长(225 分钟比 177 分钟;p<0.001)。
机器人结直肠手术与传统腹腔镜相比,在 RC 和 LC 中提高了教科书结局,具有优势。在机器人 LAR 中则没有发现这种优势,而且还显示出严重并发症的风险增加。我们研究中的关联应该在讨论结直肠癌患者的手术管理时加以考虑。